Literature DB >> 28176767

Intragenic FMR1 disease-causing variants: a significant mutational mechanism leading to Fragile-X syndrome.

Angélique Quartier1,2,3,4, Hélène Poquet5,6, Brigitte Gilbert-Dussardier7, Massimiliano Rossi8, Anne-Sophie Casteleyn9, Vincent des Portes10, Claire Feger11, Elsa Nourisson11, Paul Kuentz5,6, Claire Redin1,2,3,4, Julien Thevenon5,6, Anne-Laure Mosca-Boidron12, Patrick Callier12, Jean Muller11,13, Gaetan Lesca8, Frédéric Huet6, Véronique Geoffroy13, Salima El Chehadeh6,14, Matthieu Jung1,2,3,4, Benoit Trojak15, Stéphanie Le Gras1,2,3,4, Daphné Lehalle5, Bernard Jost1,2,3,4, Stéphanie Maury14, Alice Masurel6, Patrick Edery8, Christel Thauvin-Robinet5,6, Bénédicte Gérard11, Jean-Louis Mandel1,2,3,4,11,16,17, Laurence Faivre5,6, Amélie Piton1,11.   

Abstract

Fragile-X syndrome (FXS) is a frequent genetic form of intellectual disability (ID). The main recurrent mutagenic mechanism causing FXS is the expansion of a CGG repeat sequence in the 5'-UTR of the FMR1 gene, therefore, routinely tested in ID patients. We report here three FMR1 intragenic pathogenic variants not affecting this sequence, identified using high-throughput sequencing (HTS): a previously reported hemizygous deletion encompassing the last exon of FMR1, too small to be detected by array-CGH and inducing decreased expression of a truncated form of FMRP protein, in three brothers with ID (family 1) and two splice variants in boys with sporadic ID: a de novo variant c.990+1G>A (family 2) and a maternally inherited c.420-8A>G variant (family 3). After clinical reevaluation, the five patients presented features consistent with FXS (mean Hagerman's scores=15). We conducted a systematic review of all rare non-synonymous variants previously reported in FMR1 in ID patients and showed that six of them are convincing pathogenic variants. This study suggests that intragenic FMR1 variants, although much less frequent than CGG expansions, are a significant mutational mechanism leading to FXS and demonstrates the interest of HTS approaches to detect them in ID patients with a negative standard work-up.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28176767      PMCID: PMC5386424          DOI: 10.1038/ejhg.2016.204

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  48 in total

1.  GeneSplicer: a new computational method for splice site prediction.

Authors:  M Pertea; X Lin; S L Salzberg
Journal:  Nucleic Acids Res       Date:  2001-03-01       Impact factor: 16.971

2.  New polymorphism and a new chromosome breakpoint establish the physical and genetic mapping of DXS369 in the DXS98-FRAXA interval.

Authors:  I Oberlé; A Vincent; N Abbadi; F Rousseau; P E Hupkes; M C Hors-Cayla; S Gilgenkrantz; B A Oostra; J L Mandel
Journal:  Am J Med Genet       Date:  1991 Feb-Mar

Review 3.  Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function.

Authors:  Gary J Bassell; Stephen T Warren
Journal:  Neuron       Date:  2008-10-23       Impact factor: 17.173

Review 4.  Mutation spectra in fragile X syndrome induced by deletions of CGG*CCG repeats.

Authors:  Robert D Wells
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

5.  Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation.

Authors:  Anita Rauch; Juliane Hoyer; Sabine Guth; Christiane Zweier; Cornelia Kraus; Christian Becker; Martin Zenker; Ulrike Hüffmeier; Christian Thiel; Franz Rüschendorf; Peter Nürnberg; André Reis; Udo Trautmann
Journal:  Am J Med Genet A       Date:  2006-10-01       Impact factor: 2.802

Review 6.  Monogenic causes of X-linked mental retardation.

Authors:  J Chelly; J L Mandel
Journal:  Nat Rev Genet       Date:  2001-09       Impact factor: 53.242

Review 7.  Mosaic FMR1 deletion causes fragile X syndrome and can lead to molecular misdiagnosis: a case report and review of the literature.

Authors:  Bradford Coffee; Morna Ikeda; Dejan B Budimirovic; Lawrence N Hjelm; Walter E Kaufmann; Stephen T Warren
Journal:  Am J Med Genet A       Date:  2008-05-15       Impact factor: 2.802

8.  Nonclassical splicing mutations in the coding and noncoding regions of the ATM Gene: maximum entropy estimates of splice junction strengths.

Authors:  Laura Eng; Gabriela Coutinho; Shareef Nahas; Gene Yeo; Robert Tanouye; Mahnoush Babaei; Thilo Dörk; Christopher Burge; Richard A Gatti
Journal:  Hum Mutat       Date:  2004-01       Impact factor: 4.878

9.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals.

Authors:  François-Olivier Desmet; Dalil Hamroun; Marine Lalande; Gwenaëlle Collod-Béroud; Mireille Claustres; Christophe Béroud
Journal:  Nucleic Acids Res       Date:  2009-04-01       Impact factor: 16.971

10.  A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation.

Authors:  Patrick S Tarpey; Raffaella Smith; Erin Pleasance; Annabel Whibley; Sarah Edkins; Claire Hardy; Sarah O'Meara; Calli Latimer; Ed Dicks; Andrew Menzies; Phil Stephens; Matt Blow; Chris Greenman; Yali Xue; Chris Tyler-Smith; Deborah Thompson; Kristian Gray; Jenny Andrews; Syd Barthorpe; Gemma Buck; Jennifer Cole; Rebecca Dunmore; David Jones; Mark Maddison; Tatiana Mironenko; Rachel Turner; Kelly Turrell; Jennifer Varian; Sofie West; Sara Widaa; Paul Wray; Jon Teague; Adam Butler; Andrew Jenkinson; Mingming Jia; David Richardson; Rebecca Shepherd; Richard Wooster; M Isabel Tejada; Francisco Martinez; Gemma Carvill; Rene Goliath; Arjan P M de Brouwer; Hans van Bokhoven; Hilde Van Esch; Jamel Chelly; Martine Raynaud; Hans-Hilger Ropers; Fatima E Abidi; Anand K Srivastava; James Cox; Ying Luo; Uma Mallya; Jenny Moon; Josef Parnau; Shehla Mohammed; John L Tolmie; Cheryl Shoubridge; Mark Corbett; Alison Gardner; Eric Haan; Sinitdhorn Rujirabanjerd; Marie Shaw; Lucianne Vandeleur; Tod Fullston; Douglas F Easton; Jackie Boyle; Michael Partington; Anna Hackett; Michael Field; Cindy Skinner; Roger E Stevenson; Martin Bobrow; Gillian Turner; Charles E Schwartz; Jozef Gecz; F Lucy Raymond; P Andrew Futreal; Michael R Stratton
Journal:  Nat Genet       Date:  2009-04-19       Impact factor: 38.330

View more
  22 in total

Review 1.  Rare FMR1 gene mutations causing fragile X syndrome: A review.

Authors:  Adam F Sitzmann; Robert T Hagelstrom; Flora Tassone; Randi J Hagerman; Merlin G Butler
Journal:  Am J Med Genet A       Date:  2017-11-27       Impact factor: 2.802

Review 2.  Close encounters: Moving along bumps, breaks, and bubbles on expanded trinucleotide tracts.

Authors:  Aris A Polyzos; Cynthia T McMurray
Journal:  DNA Repair (Amst)       Date:  2017-06-09

3.  De Novo Large Deletion Leading to Fragile X Syndrome.

Authors:  Poonnada Jiraanont; Esther Manor; Nazi Tabatadze; Marwa Zafarullah; Guadalupe Mendoza; Gia Melikishvili; Flora Tassone
Journal:  Front Genet       Date:  2022-05-11       Impact factor: 4.772

Review 4.  Recent advances in assays for the fragile X-related disorders.

Authors:  Bruce E Hayward; Daman Kumari; Karen Usdin
Journal:  Hum Genet       Date:  2017-09-02       Impact factor: 4.132

Review 5.  Fragile X-related protein family: a double-edged sword in neurodevelopmental disorders and cancer.

Authors:  Mrinmoyee Majumder; Roger H Johnson; Viswanathan Palanisamy
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-09-02       Impact factor: 8.250

Review 6.  Post-translational modifications of the Fragile X Mental Retardation Protein in neuronal function and dysfunction.

Authors:  Marta Prieto; Alessandra Folci; Stéphane Martin
Journal:  Mol Psychiatry       Date:  2019-12-10       Impact factor: 15.992

7.  FMRP has a cell-type-specific role in CA1 pyramidal neurons to regulate autism-related transcripts and circadian memory.

Authors:  Jennifer C Darnell; Robert B Darnell; Kirsty Sawicka; Caryn R Hale; Christopher Y Park; John J Fak; Jodi E Gresack; Sarah J Van Driesche; Jin Joo Kang
Journal:  Elife       Date:  2019-12-20       Impact factor: 8.140

Review 8.  RNA-binding proteins in neurological development and disease.

Authors:  Shavanie Prashad; Pallavi P Gopal
Journal:  RNA Biol       Date:  2020-08-30       Impact factor: 4.652

9.  Clinical Characteristics of Fragile X Syndrome Patients in Japan.

Authors:  Tetsuya Okazaki; Kaori Adachi; Kaori Matsuura; Yoshitaka Oyama; Madoka Nose; Emi Shirahata; Toshiaki Abe; Takeshi Hasegawa; Toshiro Maihara; Yoshihiro Maegaki; Eiji Nanba
Journal:  Yonago Acta Med       Date:  2021-01-06       Impact factor: 1.641

Review 10.  Fragile X syndrome and associated disorders: Clinical aspects and pathology.

Authors:  Maria Jimena Salcedo-Arellano; Brett Dufour; Yingratana McLennan; Veronica Martinez-Cerdeno; Randi Hagerman
Journal:  Neurobiol Dis       Date:  2020-01-10       Impact factor: 7.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.